Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Johansson H, et al. Among authors: baglietto l. Breast Cancer Res Treat. 2008 Mar;108(1):57-67. doi: 10.1007/s10549-007-9577-9. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468953
Tamoxifen reduces plasma homocysteine levels in healthy women.
Cattaneo M, Baglietto L, Zighetti ML, Bettega D, Robertson C, Costa A, Mannucci PM, Decensi A. Cattaneo M, et al. Among authors: baglietto l. Br J Cancer. 1998 Jun;77(12):2264-6. doi: 10.1038/bjc.1998.376. Br J Cancer. 1998. PMID: 9649143 Free PMC article. Clinical Trial.
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Decensi A, Torrisi R, Bruno S, Costantini M, Curotto A, Nicolò G, Malcangi B, Baglietto L, Bruttini GP, Gatteschi B, Rondanina G, Varaldo M, Perloff M, Malone WF, Bruzzi P. Decensi A, et al. Among authors: baglietto l. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1071-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045790 Clinical Trial.
Epidemiology of prostate cancer.
Boyle P, Gandini S, Baglietto L, Severi G, Robertson C. Boyle P, et al. Among authors: baglietto l. Eur Urol. 2001 Apr;39 Suppl 4:2-3. doi: 10.1159/000052571. Eur Urol. 2001. PMID: 11340275 No abstract available.
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Decensi A, et al. Among authors: baglietto l. Clin Cancer Res. 2004 Jul 1;10(13):4389-97. doi: 10.1158/1078-0432.CCR-04-0087. Clin Cancer Res. 2004. PMID: 15240527 Clinical Trial.
Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer.
Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A. Serrano D, et al. Among authors: baglietto l. Clin Cancer Res. 2005 Mar 1;11(5):2083-8. doi: 10.1158/1078-0432.CCR-04-1549. Clin Cancer Res. 2005. PMID: 15756035 Clinical Trial.
246 results